GSK5733584
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GSK5733584, covering 2025-06-25 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01) [Phase 3]